Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Frontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993
Full text available